↓ Skip to main content

A Phase II Trial of Temozolomide for Patients with Recurrent or Progressive Brain Metastases

Overview of attention for article published in Journal of Neuro-Oncology, July 2001
Altmetric Badge

Mentioned by

twitter
6 X users

Citations

dimensions_citation
201 Dimensions

Readers on

mendeley
34 Mendeley
Title
A Phase II Trial of Temozolomide for Patients with Recurrent or Progressive Brain Metastases
Published in
Journal of Neuro-Oncology, July 2001
DOI 10.1023/a:1012226718323
Pubmed ID
Authors

Lauren E. Abrey, Jon D. Olson, Jeffrey J. Raizer, Michelle Mack, Ann Rodavitch, Dina Y. Boutros, Mark G. Malkin

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Brazil 1 3%
Unknown 32 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 26%
Student > Postgraduate 4 12%
Researcher 3 9%
Student > Master 3 9%
Student > Bachelor 2 6%
Other 7 21%
Unknown 6 18%
Readers by discipline Count As %
Medicine and Dentistry 22 65%
Biochemistry, Genetics and Molecular Biology 2 6%
Neuroscience 1 3%
Mathematics 1 3%
Unknown 8 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2019.
All research outputs
#14,387,928
of 25,373,627 outputs
Outputs from Journal of Neuro-Oncology
#1,764
of 3,257 outputs
Outputs of similar age
#36,591
of 40,893 outputs
Outputs of similar age from Journal of Neuro-Oncology
#5
of 6 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,257 research outputs from this source. They receive a mean Attention Score of 4.4. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 40,893 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.